Little did I realize a few grapes could send my blood sugar soaring until I tried the first glucose monitor without a ...

DexCom's revised FY24 sales guidance in the Q2 earnings call led to a $18bn valuation reset. Read why I think DXCM stock is a ...

New continuous glucose monitoring sensors (small sensors that penetrate the skin to measure glucose levels in real time) are ...

An exciting market opportunity for DexCom is to offer a solution for people who don't require insulin injections or even ...

Retta reveals the first symptoms of her Type 2 diabetes. The actor shares the lifestyle changes she made and the glucose ...

Dexcom‘s Stelo glucose monitor is for those people and I’ve found it works pretty well. It’s available today as the first blood sugar monitor for people who don’t have diabetes yet ...

Today, Benzinga 's options scanner spotted 8 uncommon options trades for DexCom. This isn't normal. The overall sentiment of ...

DexCom (NASDAQ: DXCM) is a big name in diabetes care. Its continuous glucose monitors (CGMs) help people track their blood glucose levels. But the stock has been performing poorly this year amid ...

Though built on the same sensor platform, the Stelo will operate without the low blood ... (Dexcom) Launching an over-the-counter glucose biosensing device expands access to continuous glucose ...

Dexcom announced today that its G6 continuous glucose monitor (CGM) is being worn by astronauts as part of the Polaris Dawn ...

people who don’t take insulin and those with prediabetes who simply want to track their blood glucose levels. Dexcom released Stelo, the first FDA-approved continuous glucose monitor that doesn ...